Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian
Novel issues in the combined modality treatment of lymphomas
Immunotherapy highlights from ICML 2017
The circle of CLL
Carlo Croce et al.
How does a patient’s personal situation affect CLL treatment choice?